Lexeo Therapeutics, Inc. (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

5.50

-0.26 (-4.51%)

At close: May 14, 2026, 4:00 PM EDT

5.51

+0.01 (0.18%)

After-hours: May 14, 2026, 6:35 PM EDT

Lexeo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	71.77	63	35.01	121.47	77.34	135.86
Short-Term Investments	121.28	118.77	86.5	-	-	-
Cash & Short-Term Investments	193.04	181.77	121.52	121.47	77.34	135.86
Cash Growth	93.37%	49.58%	0.04%	57.06%	-43.08%	362.53%
Other Current Assets	7.82	6.63	4.6	2.83	2.71	0.82
Total Current Assets	200.86	188.39	126.12	124.29	80.05	136.68
Net Property, Plant & Equipment	8.35	8.86	10.56	12.26	13.78	0.17
Long-Term Investments	37.9	68.19	7.01	-	-	-
Other Long-Term Assets	3.25	3.25	3.25	3.25	3.25	0
Total Assets	250.36	268.69	146.94	139.81	97.08	136.86
Accounts Payable	3.34	4.86	6.42	3.79	2.68	3.06
Accrued Expenses	8.16	9.28	13.76	10.84	8.33	3.81
Current Portion of Leases	2.7	2.68	2.67	2.61	2.83	-
Unearned Revenue	-	-	-	-	-	0.05
Other Current Liabilities	-	-	-	-	0.51	0.53
Total Current Liabilities	14.19	16.81	22.85	17.24	14.35	7.45
Long-Term Leases	4.67	5.21	7.25	9.03	10.65	-
Total Long-Term Liabilities	4.67	5.21	7.25	9.03	10.65	-
Total Liabilities	18.86	22.02	30.1	26.27	25	7.45
Common Stock	0.01	0.01	0	0	-	-
Treasury Stock	-0.02	-0.02	-0.02	-	-	-
Additional Paid-in Capital	631.98	626.63	397.13	295.37	2.49	0.57
Accumulated Other Comprehensive Income	-0.14	0.19	-0.1	-	-	-
Retained Earnings	-400.33	-380.13	-280.17	-181.84	-115.45	-56.17
Total Common Shareholders' Equity	231.5	246.67	116.84	113.54	-112.95	-55.6
Minority Interest	-	-	-	-	185.03	185.01
Shareholders' Equity	231.5	246.67	116.84	113.54	72.08	129.41
Total Liabilities & Equity	250.36	268.69	146.94	139.81	97.08	136.86
Total Debt	7.37	7.89	9.92	11.64	13.48	0
Net Cash (Debt)	185.68	173.88	111.59	109.83	63.85	135.86
Net Cash Growth	6.78%	55.82%	1.61%	72.00%	-53.00%	362.53%
Net Cash Per Share	2.83	3.24	3.51	20.51	39.16	87.50
Book Value	231.5	246.67	116.84	113.54	-112.95	-55.6
Book Value Per Share	3.53	4.60	3.68	21.20	-69.28	-35.81
Tangible Book Value	231.5	246.67	116.84	113.54	-112.95	-55.6
Tangible Book Value Per Share	3.53	4.60	3.68	21.20	-69.28	-35.81

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q